Prognostic value of procalcitonin in infection-related mortality of cancer patients


Sedef A. M. , Kose F., Sumbul A. T. , Dogan O., Kursun E., Yurdakul Z., ...More

JOURNAL OF BUON, vol.21, no.3, pp.740-744, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 3
  • Publication Date: 2016
  • Title of Journal : JOURNAL OF BUON
  • Page Numbers: pp.740-744

Abstract

Purpose: Infectious diseases are a major cause of morbidity and mortality in cancer patients. Tumor-induced inflammatory responses may increase the value of classical inflammatory markers in blood, so these markers may not be as useful in cancer patients as in non-cancer patients. Serum procalcitonin (PCT) is a sensitive and specific biomarker for severe infection, and has been shown to be unaffected by tumor-induced inflammatory response. In this study we aimed to evaluate the possible role of PCT in mortality in cancer patients with infection.